JPS56166117A - Antiinflammatory and analgesic adenosine derivative and therapeutical composition containing it as effective component - Google Patents

Antiinflammatory and analgesic adenosine derivative and therapeutical composition containing it as effective component

Info

Publication number
JPS56166117A
JPS56166117A JP5930181A JP5930181A JPS56166117A JP S56166117 A JPS56166117 A JP S56166117A JP 5930181 A JP5930181 A JP 5930181A JP 5930181 A JP5930181 A JP 5930181A JP S56166117 A JPS56166117 A JP S56166117A
Authority
JP
Japan
Prior art keywords
antiinflammatory
analgesic
composition containing
effective component
adenosine derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5930181A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0249288B2 (US20020051482A1-20020502-M00012.png
Inventor
Sutoramenchinori Jiyorujio
Gennari Fuederiko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioresearch SRL
Original Assignee
Bioresearch SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch SRL filed Critical Bioresearch SRL
Publication of JPS56166117A publication Critical patent/JPS56166117A/ja
Publication of JPH0249288B2 publication Critical patent/JPH0249288B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP5930181A 1980-04-22 1981-04-21 Antiinflammatory and analgesic adenosine derivative and therapeutical composition containing it as effective component Granted JPS56166117A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21550/80A IT1193529B (it) 1980-04-22 1980-04-22 Derivati adenosinici ad attivita' antinfiammatoria ed analgesica e composizioni terapeutiche che li contengono come principio attivo

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP1022771A Division JPH01301692A (ja) 1980-04-22 1989-02-02 5’―デオキシ―5’―メチルチオアデノシンの新規な製造方法

Publications (2)

Publication Number Publication Date
JPS56166117A true JPS56166117A (en) 1981-12-21
JPH0249288B2 JPH0249288B2 (US20020051482A1-20020502-M00012.png) 1990-10-29

Family

ID=11183457

Family Applications (2)

Application Number Title Priority Date Filing Date
JP5930181A Granted JPS56166117A (en) 1980-04-22 1981-04-21 Antiinflammatory and analgesic adenosine derivative and therapeutical composition containing it as effective component
JP1022771A Granted JPH01301692A (ja) 1980-04-22 1989-02-02 5’―デオキシ―5’―メチルチオアデノシンの新規な製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP1022771A Granted JPH01301692A (ja) 1980-04-22 1989-02-02 5’―デオキシ―5’―メチルチオアデノシンの新規な製造方法

Country Status (17)

Country Link
JP (2) JPS56166117A (US20020051482A1-20020502-M00012.png)
AR (1) AR231144A1 (US20020051482A1-20020502-M00012.png)
BE (1) BE888472A (US20020051482A1-20020502-M00012.png)
CA (1) CA1198105A (US20020051482A1-20020502-M00012.png)
CH (2) CH645544A5 (US20020051482A1-20020502-M00012.png)
DE (1) DE3116067A1 (US20020051482A1-20020502-M00012.png)
DK (1) DK159453C (US20020051482A1-20020502-M00012.png)
ES (2) ES501539A0 (US20020051482A1-20020502-M00012.png)
FI (1) FI70227C (US20020051482A1-20020502-M00012.png)
FR (1) FR2491761A1 (US20020051482A1-20020502-M00012.png)
GB (3) GB2074446B (US20020051482A1-20020502-M00012.png)
IT (1) IT1193529B (US20020051482A1-20020502-M00012.png)
LU (1) LU83307A1 (US20020051482A1-20020502-M00012.png)
MX (1) MX9203630A (US20020051482A1-20020502-M00012.png)
NL (1) NL192111C (US20020051482A1-20020502-M00012.png)
NO (1) NO150515C (US20020051482A1-20020502-M00012.png)
SE (3) SE460198B (US20020051482A1-20020502-M00012.png)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61140599A (ja) * 1984-12-06 1986-06-27 バイオリサーチ・エス.ピー.エー 5’‐メチルチオ‐5’‐デオキシアデノシンと長鎖アルキルスルホン酸との塩
JPH0278621A (ja) * 1988-07-29 1990-03-19 Bioresearch Spa 免疫促進活性を有する製薬組成物の調製に於けるアデノシン誘導体の使用
JP2008533107A (ja) * 2005-03-17 2008-08-21 プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ 自己免疫疾患および/または移植拒絶反応の予防および/または治療における5’−メチルチオアデノシン(mta)の使用
WO2014163152A1 (ja) * 2013-04-05 2014-10-09 ライオン株式会社 ノンレム睡眠促進剤、深睡眠促進剤および自然睡眠誘発剤
WO2014163150A1 (ja) * 2013-04-05 2014-10-09 ライオン株式会社 内服組成物

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0497287A (ja) * 1990-08-10 1992-03-30 Nec Ic Microcomput Syst Ltd 画像表示集積回路
ES2259552B1 (es) * 2005-03-17 2007-06-16 Proyecto De Biomedicina Cima, S.L. Empleo de 5'-metiltioadenosina (mta) en la prevencion y/o tratamiento de enfermedades autoinmunes y/o rechazo de transplantes.
DE102010027595A1 (de) * 2010-07-23 2012-01-26 Helmut Vorbrüggen Vermeidung von Ischämie- oder Degenerations-Schäden im Gehirn bei Anwendung von Adenosin-Derivaten
DE102011005232A1 (de) * 2011-03-08 2012-09-13 AristoCon GmbH & Co. KG Adenosin und seine Derivate zur Verwendung in der Schmerztherapie
WO2014163151A1 (ja) * 2013-04-05 2014-10-09 ライオン株式会社 酵母培養物及び内服組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52125633A (en) * 1975-06-09 1977-10-21 Anvar Medicine based on adenosinee55 thioether
JPS54145222A (en) * 1978-04-28 1979-11-13 Merieux Inst Novel medicine * especially anodyne and sleep inducer and medical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1259341B (de) * 1962-12-22 1968-01-25 Boehringer & Soehne Gmbh Verfahren zur Herstellung neuer 5'-Sulfoxyde von Nucleosiden
DE1545645A1 (de) * 1965-12-06 1969-08-21 Boehringer Mannheim Gmbh Verfahren zur Herstellung von disubstituierten Adenosin-Derivaten
FR2252405B1 (US20020051482A1-20020502-M00012.png) * 1973-11-27 1978-04-28 Ajinomoto Kk

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52125633A (en) * 1975-06-09 1977-10-21 Anvar Medicine based on adenosinee55 thioether
JPS54145222A (en) * 1978-04-28 1979-11-13 Merieux Inst Novel medicine * especially anodyne and sleep inducer and medical composition

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61140599A (ja) * 1984-12-06 1986-06-27 バイオリサーチ・エス.ピー.エー 5’‐メチルチオ‐5’‐デオキシアデノシンと長鎖アルキルスルホン酸との塩
JPH0160478B2 (US20020051482A1-20020502-M00012.png) * 1984-12-06 1989-12-22 Bioresearch Spa
JPH0278621A (ja) * 1988-07-29 1990-03-19 Bioresearch Spa 免疫促進活性を有する製薬組成物の調製に於けるアデノシン誘導体の使用
JP2611003B2 (ja) * 1988-07-29 1997-05-21 バイオリサーチ エス ピー エイ 免疫促進剤
JP2008533107A (ja) * 2005-03-17 2008-08-21 プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ 自己免疫疾患および/または移植拒絶反応の予防および/または治療における5’−メチルチオアデノシン(mta)の使用
WO2014163152A1 (ja) * 2013-04-05 2014-10-09 ライオン株式会社 ノンレム睡眠促進剤、深睡眠促進剤および自然睡眠誘発剤
WO2014163150A1 (ja) * 2013-04-05 2014-10-09 ライオン株式会社 内服組成物
JPWO2014163152A1 (ja) * 2013-04-05 2017-02-16 ライオン株式会社 ノンレム睡眠促進剤、深睡眠促進剤および自然睡眠誘発剤
JPWO2014163150A1 (ja) * 2013-04-05 2017-02-16 ライオン株式会社 内服組成物

Also Published As

Publication number Publication date
GB2144409B (en) 1985-09-11
JPH0246599B2 (US20020051482A1-20020502-M00012.png) 1990-10-16
FR2491761B1 (US20020051482A1-20020502-M00012.png) 1984-01-06
GB8321947D0 (en) 1983-09-14
SE466238B (sv) 1992-01-20
CH650514A5 (de) 1985-07-31
ES8206551A1 (es) 1982-08-16
NO811346L (no) 1981-10-23
NO150515B (no) 1984-07-23
SE8700914D0 (sv) 1987-03-04
IT1193529B (it) 1988-07-08
CA1198105A (en) 1985-12-17
NL192111B (nl) 1996-10-01
GB2144038A (en) 1985-02-27
SE8700913L (sv) 1987-03-04
DE3116067C2 (US20020051482A1-20020502-M00012.png) 1992-12-17
DK159453C (da) 1991-03-18
JPH01301692A (ja) 1989-12-05
SE8700914L (sv) 1987-03-04
GB2074446A (en) 1981-11-04
FI70227C (fi) 1986-09-15
NL8101984A (nl) 1981-11-16
IT8021550A0 (it) 1980-04-22
SE8102489L (sv) 1981-10-23
SE464635B (sv) 1991-05-27
GB8413454D0 (en) 1984-07-04
FR2491761A1 (fr) 1982-04-16
SE8700913D0 (sv) 1987-03-04
SE460198B (sv) 1989-09-18
ES501539A0 (es) 1982-08-16
DE3116067A1 (de) 1982-03-11
BE888472A (fr) 1981-08-17
GB2074446B (en) 1985-04-11
AR231144A1 (es) 1984-09-28
ES511039A0 (es) 1983-06-01
DK159453B (da) 1990-10-15
CH645544A5 (de) 1984-10-15
ES8306378A1 (es) 1983-06-01
LU83307A1 (fr) 1981-07-24
GB2144409A (en) 1985-03-06
NL192111C (nl) 1997-02-04
DK176481A (da) 1981-10-23
JPH0249288B2 (US20020051482A1-20020502-M00012.png) 1990-10-29
MX9203630A (es) 1992-09-01
FI70227B (fi) 1986-02-28
NO150515C (no) 1984-10-31
GB2144038B (en) 1985-08-29
FI811249L (fi) 1981-10-23

Similar Documents

Publication Publication Date Title
DE3172516D1 (en) Penetrating topical pharmaceutical compositions
JPS56113782A (en) Organic compound* medicinal composition containing it and manufacture thereof
GB2071670B (en) Nutrient compositions and methods of administering the same
GB8503878D0 (en) Dermatological composition
DE3273329D1 (en) Analgesic process and composition
DE3172379D1 (en) D-xylopyranoside series compounds and therapeutical compositions containing same
JPS56141834A (en) Composition of neutralizer
JPS54148730A (en) Mildewwkilling acylanilide derivative*its manufacture and composition containing it
GB8406704D0 (en) Analgesic and antiinflammatory compositions
JPS56166117A (en) Antiinflammatory and analgesic adenosine derivative and therapeutical composition containing it as effective component
GB2083355B (en) Method and composition for reducing the toxicity of acetaminophen
JPS56122381A (en) Pyrano derivative* its manufacture and medicinal composition containing it
GB8317357D0 (en) Therapeutic composition
GB2047534B (en) Analgesic and myotonolytic compositions
JPS57167963A (en) Therapeutical n-acetylcystin derivative, manufacture and related pharmacetical compositions
JPS5517385A (en) Benzimidazolinone derivative and medical composition containing it
JPS552698A (en) Thienooor furopyridone derivative* its manufacture and therapeutic composition containing it
EP0051789A3 (en) Therapeutic composition
JPS56103169A (en) Phenyll11morpholinoo44butenee11oll3 derivative* its manufacture and therapeutic application
JPS54138563A (en) Dichlorobenzodioxol derivative*its manufacture and arthropodkilling composition containing it
JPS5699472A (en) 11aminoopropanee22ol derivative* its manufacture and therapeutical composition
JPS56108780A (en) Prostanid compound*its manufacture and drug composition
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions
GB2077265B (en) N-trifluoroacetyladriamycin-14-o-hemiglutarate and hemiadipate and therapeutic compositions containing the same
JPS5775642A (en) Emuslsion composition for maintaining therapeutic instrument